992
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Development of a super-hydrophilic anaerobic tube for the optimization of platelet-rich fibrin

, , , , , , ORCID Icon & show all
Article: 2316745 | Received 30 Nov 2022, Accepted 05 Feb 2024, Published online: 22 Feb 2024

References

  • Wei Y, Cheng Y, Wang Y, Zhang X, Miron RJ, Zhang Y. The effect of resting and compression time post-centrifugation on the characteristics of platelet rich fibrin (PRF) membranes. Clin Oral Investig. 2022;26(8):5281–12. doi:10.1007/s00784-022-04496-9.
  • Honda Y, Morishima Y. Thrombin generation induced by tissue factor plus ADP in human platelet rich plasma: a potential new measurement to assess the effect of the concomitant use of an oral factor Xa inhibitor edoxaban and P2Y12 receptor antagonists. Thromb Res. 2015;135(5):958–62. doi:10.1016/j.thromres.2015.03.001.
  • Lee JS, Guo P, Klett K, Hall M, Sinha K, Ravuri S, Huard J, Murphy WL. VEGF-attenuated platelet-rich plasma improves therapeutic effect on cartilage repair. Biomater Sci. 2022;10:2172–81. doi:10.1039/d1bm01873f.
  • Lei L, Yu Y, Han J, Shi D, Sun W, Zhang D, Chen L. Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficacy as adjunctive to the GTR procedure in periodontal intrabony defects. J Periodontol. 2020;91:462–72. doi:10.1002/JPER.19-0290.
  • Li Z, Liu L, Wang L, Song D. The effects and potential applications of concentrated growth factor in dentin-pulp complex regeneration. Stem Cell Res Ther. 2021;12:357. doi:10.1186/s13287-021-02446-y.
  • Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24:227–34. doi:10.1016/j.tibtech.2006.02.010.
  • Miron RJ, Chai J, Zheng S, Feng M, Sculean A, Zhang Y. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation. J Biomed Mater Res A. 2019;107:2257–71. doi:10.1002/jbm.a.36734.
  • Feng M, Wang Y, Zhang P, Zhao Q, Yu S, Shen K, Miron RJ, Zhang Y. Antibacterial effects of platelet-rich fibrin produced by horizontal centrifugation. Int J Oral Sci. 2020;12:32. doi:10.1038/s41368-020-00099-w.
  • Miron RJ. Understanding platelet rich fibrin: quintessence. 2021.
  • Kobayashi E, Fluckiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, Miron RJ. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig. 2016;20:2353–60. doi:10.1007/s00784-016-1719-1.
  • Castro AB, Meschi N, Temmerman A, Pinto N, Lambrechts P, Teughels W, Quirynen M. Regenerative potential of leucocyte- and platelet-rich fibrin. Part A: intra-bony defects, furcation defects and periodontal plastic surgery. A systematic review and meta-analysis. J Clin Periodontol. 2017;44:67–82. doi:10.1111/jcpe.12643.
  • Egle K, Salma I, Dubnika A. From blood to regenerative tissue: how autologous platelet-rich fibrin can Be combined with other materials to ensure controlled drug and growth factor release. IJMS. 2021;22:11553. doi:10.3390/ijms222111553.
  • Bi J, Intriago MFB, Koivisto L, Jiang G, Hakkinen L, Larjava H. Leucocyte- and platelet-rich fibrin regulates expression of genes related to early wound healing in human gingival fibroblasts. J Clin Periodontol. 2020;47:851–62. doi:10.1111/jcpe.13293.
  • Mirhaj M, Tavakoli M, Varshosaz J, Labbaf S, Jafarpour F, Ahmaditabar P, Salehi S, Kazemi N. Platelet rich fibrin containing nanofibrous dressing for wound healing application: fabrication, characterization and biological evaluations. Biomater Adv. 2022;134:112541. doi:10.1016/j.msec.2021.112541.
  • Wang J, Sun Y, Liu Y, Yu J, Sun X, Wang L, Zhou Y. Effects of platelet-rich fibrin on osteogenic differentiation of schneiderian membrane derived mesenchymal stem cells and bone formation in maxillary sinus. Cell Commun Signal. 2022;20:88. doi:10.1186/s12964-022-00844-0.
  • Kardos D, Hornyak I, Simon M, Hinsenkamp A, Marschall B, Vardai R, Kallay-Menyhard A, Pinke B, Meszaros L, Kuten O. et al. Biological and mechanical properties of platelet-rich fibrin membranes after thermal manipulation and preparation in a single-syringe closed system. IJMS. 2018;19:3433. doi:10.3390/ijms19113433.
  • Kargarpour Z, Panahipour L, Miron RJ, Gruber R. Fibrinogen concentrations in liquid PRF using various centrifugation protocols. Molecules. 2022;27. doi:10.3390/molecules27072043.
  • Barbu HM, Iancu SA, Rapani A, Stacchi C. Guided bone regeneration with concentrated growth factor enriched bone graft matrix (sticky bone) vs. bone-shell technique in horizontal ridge augmentation: a retrospective study. JCM. 2021;10:3953. doi:10.3390/jcm10173953.
  • Tony JB, Parthasarathy H, Tadepalli A, Ponnaiyan D, Alamoudi A, Kamil MA, Alzahrani KJ, Alsharif KF, Halawani IF, Alnfiai MM. et al. CBCT evaluation of sticky bone in horizontal Ridge augmentation with and without collagen membrane—a randomized parallel arm clinical trial. JFB. 2022;13:194. doi:10.3390/jfb13040194.
  • Miron RJ, Zucchelli G, Pikos MA, Salama M, Lee S, Guillemette V, Fujioka-Kobayashi M, Bishara M, Zhang Y, Wang HL. et al. Use of platelet-rich fibrin in regenerative dentistry: a systematic review. Clin Oral Investig. 2017;21(6):1913–27. doi:10.1007/s00784-017-2133-z.
  • Miron RJ, Dham A, Dham U, Zhang Y, Pikos MA, Sculean A. The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet-rich fibrin (PRF) membranes. Clin Oral Investig. 2019;23:2179–85. doi:10.1007/s00784-018-2673-x.
  • Al-Maawi S, Dohle E, Lim J, Weigl P, Teoh SH, Sader R, Ghanaati S. Biologization of pcl-mesh using platelet rich fibrin (Prf) enhances its regenerative potential in vitro. IJMS. 2021;22:2159. doi:10.3390/ijms22042159.
  • Reksodiputro MH, Harahap AR, Setiawan L, Yosia M. A modified preparation method of ideal platelet-rich fibrin matrix from whole blood. Front Med. 2021;8:724488. doi:10.3389/fmed.2021.724488.
  • Aizawa H, Tsujino T, Watanabe T, Isobe K, Kitamura Y, Sato A, Yamaguchi S, Okudera H, Okuda K, Kawase T. Quantitative near-infrared imaging of platelets in platelet-rich fibrin (PRF) matrices: comparative analysis of bio-PRF, leukocyte-rich PRF, advanced-PRF and concentrated growth factors. IJMS. 2020;21:4426. doi:10.3390/ijms21124426.
  • Tsujino T, Masuki H, Nakamura M, Isobe K, Kawabata H, Aizawa H, Watanabe T, Kitamura Y, Okudera H, Okuda K. et al. Striking differences in platelet distribution between advanced-platelet-rich fibrin and concentrated growth factors: effects of silica-containing plastic tubes. JFB. 2019;10:43. doi:10.3390/jfb10030043.
  • Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier JB. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane. J Periodontol. 2010;81:546–55. doi:10.1902/jop.2009.090531.
  • Cameron SJ, Mix DS, Ture SK, Schmidt RA, Mohan A, Pariser D, Stoner MC, Shah P, Chen L, Zhang H. et al. Hypoxia and ischemia promote a maladaptive platelet phenotype. Arterioscler Thromb Vasc Biol. 2018;38:1594–606. doi:10.1161/ATVBAHA.118.311186.
  • Kusanto B, Gordon A, Naylor-Adamson L, Atkinson L, Coupland C, Booth Z, Ahmed Y, Pires IM, Stasiuk GJ, Sturmey R. et al. Practical considerations of dissolved oxygen levels for platelet function under hypoxia. IJMS. 2021;22:13223. doi:10.3390/ijms222413223.
  • Tyagi T, Ahmad S, Gupta N, Sahu A, Ahmad Y, Nair V, Chatterjee T, Bajaj N, Sengupta S, Ganju L. et al. Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype. Blood. 2014;123(8):1250–60. doi:10.1182/blood-2013-05-501924.
  • Vogler EA, Graper JC, Harper GR, Sugg HW, Lander LM, Brittain WJ. Contact activation of the plasma coagulation cascade. I. Procoagulant surface chemistry and energy. J Biomed Mater Res. 1995;29:1005–16. doi:10.1002/jbm.820290813.
  • Zhuo R, Miller R, Bussard KM, Siedlecki CA, Vogler EA. Procoagulant stimulus processing by the intrinsic pathway of blood plasma coagulation. Biomaterials. 2005;26:2965–73. doi:10.1016/j.biomaterials.2004.08.008.
  • Wittenburg G, Lauer G, Oswald S, Labudde D, Franz CM. Nanoscale topographic changes on sterilized glass surfaces affect cell adhesion and spreading. J Biomed Mater Res A. 2014;102:2755–66. doi:10.1002/jbm.a.34943.
  • Crespin M, Moreau N, Masereel B, Feron O, Gallez B, Vander Borght T, Michiels C, Lucas S. Surface properties and cell adhesion onto allylamine-plasma and amine-plasma coated glass coverslips. J Mater Sci Mater Med. 2011;22:671–82. doi:10.1007/s10856-011-4245-3.
  • Moradi S, Hadjesfandiari N, Toosi SF, Kizhakkedathu JN, Hatzikiriakos SG. Effect of extreme wettability on platelet adhesion on metallic implants: from superhydrophilicity to Superhydrophobicity. ACS Appl Mater Interfaces. 2016;8:17631–41. doi:10.1021/acsami.6b03644.
  • van Rensburg WJ J, van der Merwe P. Comparison of commercially available blood collection tubes containing sodium citrate and hirudin in platelet aggregation testing. Med Sci Monit Basic Res. 2017;23:264–9. doi:10.12659/msmbr.905246.
  • Schneider DJ, Tracy PB, Mann KG, Sobel BE. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation. 1997;96:2877–83. doi:10.1161/01.cir.96.9.2877.
  • Wei Y, Zhu G, Zhao Z, Yin C, Zhao Q, Xu H, Wang J, Zhang J, Zhang X, Zhang Y. et al. Individualized plasticity autograft mimic with efficient bioactivity inducing osteogenesis. Int J Oral Sci. 2021;13(1):14. doi:10.1038/s41368-021-00120-w.
  • Di Liddo R, Bertalot T, Borean A, Pirola I, Argentoni A, Schrenk S, Cenzi C, Capelli S, Conconi MT, Parnigotto PP. Leucocyte and platelet-rich fibrin: a carrier of autologous multipotent cells for regenerative medicine. J Cell Mol Med. 2018;22:1840–54. doi:10.1111/jcmm.13468.
  • Polak D, Clemer-Shamai N, Shapira L. Incorporating antibiotics into platelet-rich fibrin: a novel antibiotics slow-release biological device. J Clin Periodontol. 2019;46:241–7. doi:10.1111/jcpe.13063.
  • Wang X, Fok MR, Pelekos G, Jin L, Tonetti MS. Increased local concentrations of growth factors from leucocyte- and platelet-rich fibrin do not translate into improved alveolar ridge preservation: an intra-individual mechanistic randomized controlled trial. J Clin Periodontol. 2022;49:889–98. doi:10.1111/jcpe.13688.
  • Koca-Unsal RB, Unsal G, Kasnak G, Firatli Y, Ozcan I, Orhan K, Firatli E. Ultrasonographic evaluation of the titanium-prepared platelet-rich fibrin effect in free gingival graft procedures. J Periodontol. 2022;93:187–94. doi:10.1002/JPER.21-0076.
  • Keceli HG, Kamak G, Erdemir EO, Evginer MS, Dolgun A. The adjunctive effect of platelet-rich fibrin to connective tissue graft in the treatment of buccal recession defects: results of a randomized, parallel-group controlled trial. J Periodontol. 2015;86:1221–30. doi:10.1902/jop.2015.150015.
  • Xin L, Yuan S, Mu Z, Li D, Song J, Chen T. Histological and histomorphometric evaluation of applying a bioactive advanced platelet-rich fibrin to a perforated schneiderian membrane in a maxillary sinus elevation model. Front Bioeng Biotechnol. 2020;8:600032. doi:10.3389/fbioe.2020.600032.
  • Oncu E, Kaymaz E. Assessment of the effectiveness of platelet rich fibrin in the treatment of schneiderian membrane perforation. Clin Implant Dent Relat Res. 2017;19:1009–14. doi:10.1111/cid.12528.
  • Sultan T, Cheah CW, Ibrahim NB, Asif MK, Vaithilingam RD. Three-dimensional assessment of the extraction sockets, augmented with platelet-rich fibrin and calcium sulfate: a clinical pilot study. J Dent. 2020;101:103455. doi:10.1016/j.jdent.2020.103455.
  • Gheno E, Alves GG, Ghiretti R, Mello-Machado RC, Signore A, Lourenco ES, Leite PEC, Mourao C, Sohn DS, Calasans-Maia MD. “Sticky Bone” preparation device: a pilot study on the release of cytokines and growth factors. Mater (Basel). 2022;15:1474. doi:10.3390/ma15041474.
  • Miron RJ, Zhang Y. Autologous liquid platelet rich fibrin: a novel drug delivery system. Acta Biomater. 2018;75:35–51. doi:10.1016/j.actbio.2018.05.021.
  • Serafini G, Lopreiato M, Lollobrigida M, Lamazza L, Mazzucchi G, Fortunato L, Mariano A, Scotto d’Abusco A, Fontana M, De Biase A. Platelet rich fibrin (PRF) and its related products: biomolecular characterization of the liquid fibrinogen. J Clin Med. 2020;9:1099. doi:10.3390/jcm9041099.
  • Soe G, Kohno I, Inuzuka K, Itoh Y, Matsuda M. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma. Blood. 1996;88(6):2109–2117. doi:10.1182/blood.V88.6.2109.bloodjournal8862109.
  • Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894–904. doi:10.1111/j.1538-7836.2005.01365.x.
  • Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci. 2001;936:11–30. doi:10.1111/j.1749-6632.2001.tb03491.x.
  • Yang Z, Mochalkin I, Doolittle RF. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci U S A. 2000;97:14156–61. doi:10.1073/pnas.97.26.14156.
  • Bilezikian SB, Nossel HL, Butler VP Jr., Canfield RE. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. J Clin Invest. 1975;56:438–45. doi:10.1172/JCI108110.
  • Zhuo R, Siedlecki CA, Vogler EA. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces. Biomaterials. 2006;27:4325–32. doi:10.1016/j.biomaterials.2006.04.001.
  • Mitchell JL, Lionikiene AS, Fraser SR, Whyte CS, Booth NA, Mutch NJ. Functional factor XIII-A is exposed on the stimulated platelet surface. Blood. 2014;124:3982–90. doi:10.1182/blood-2014-06-583070.
  • Somodi L, Beke Debreceni I, Kis G, Cozzolino M, Kappelmayer J, Antal M, Panyi G, Bardos H, Mutch NJ, Muszbek L. Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles. J Thromb Haemost. 2022;20:1223–35. doi:10.1111/jth.15668.
  • Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000;96:988–95. doi:10.1182/blood.V96.3.988.
  • van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16:166–79. doi:10.1038/s41569-018-0110-0.
  • Rodrigues BL, Montalvao SAL, Cancela RBB, Silva FAR, Urban A, Huber SC, Junior J, Lana J, Annichinno-Bizzacchi JM. Treatment of male pattern alopecia with platelet-rich plasma: a double-blind controlled study with analysis of platelet number and growth factor levels. J Am Acad Dermatol. 2019;80:694–700. doi:10.1016/j.jaad.2018.09.033.
  • Hamilton B, Tol JL, Knez W, Chalabi H. Exercise and the platelet activator calcium chloride both influence the growth factor content of platelet-rich plasma (PRP): overlooked biochemical factors that could influence PRP treatment. Br J Sports Med. 2015;49:957–60. doi:10.1136/bjsports-2012-091916.
  • Ruvalcaba-Ontiveros RI, Gonzalez-Chavez SA, Carrasco-Hernandez AR, Lopez-Loeza SM, Castellanos-Ponce I, Vazquez-Olvera G, Neri-Flores MA, Espino-Solis GP, Duarte-Moller JA, Pacheco-Tena C. et al. Treatment with silica–gold nanostructures decreases inflammation-related gene expression in collagen-induced arthritis. Biomater Sci. 2022;10:5216–29. doi:10.1039/d2bm00498d.
  • Ungerer M, Rosport K, Bultmann A, Piechatzek R, Uhland K, Schlieper P, Gawaz M, Munch G. Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation. 2011;123:1891–9. doi:10.1161/CIRCULATIONAHA.110.980623.
  • Arbesu I, Bucsaiova M, Fischer MB, Mannhalter C. Platelet-borne complement proteins and their role in platelet-bacteria interactions. J Thromb Haemost. 2016;14:2241–52. doi:10.1111/jth.13495.
  • Cognasse F, Laradi S, Berthelot P, Bourlet T, Marotte H, Mismetti P, Garraud O, Hamzeh-Cognasse H. Platelet inflammatory response to stress. Front Immunol. 2019;10:1478. doi:10.3389/fimmu.2019.01478.
  • Kossmann S, Lagrange J, Jackel S, Jurk K, Ehlken M, Schonfelder T, Weihert Y, Knorr M, Brandt M, Xia N. et al. Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension. Sci Transl Med. 2017;9. doi:10.1126/scitranslmed.aah4923.